Versantis' Grant

Versantis raised a round of funding on November 02, 2016. Investors include MassChallenge.

Versantis is a pharmaceutical company that focuses on the development of products for the diagnosis, prevention, and treatment of liver diseases. Its lead candidate, VS-01, targets hepatic encephalopa…

Articles about Versantis' Grant: